Search Within

Shanu Modi

  1. "Cancer Research"
Formats
  1. Meeting Abstract (50)
Groups
  1. Breast Medicine Service (50)
  2. Department of Medicine (50)
  3. Solid Tumor Oncology Division (50)
  4. GSK Faculty (24)
  5. Survivorship Research (23)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (21)

More Groups

People
  1. Clifford Hudis (18)
  2. Sarat Chandarlapaty (13)
  3. Sujata Patil (13)
  4. Larry Norton (12)
  5. Diana Lake (11)
  6. Gabriella D'Andrea-Carlino (10)

More People

Years
  1. 2022 (2)
  2. 2021 (5)
  3. 2020 (4)
  4. 2019 (5)
  5. 2018 (3)
  6. 2017 (2)

More Years

Publications
  1. Cancer Research (50)
Publishers
  1. American Association for Cancer Research (50)

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Meeting Abstract

    Liu, B.; Drago, J. Z.; Rao, Y.; Pereira, P. R.; Safonov, A.; Marra, A.; Ahmed, M. S.; Modi, S.; Reis, J. S.; Montemurro, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
    Meeting Abstract

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pooled analysis of drug-related interstitial lung disease (ILD) in 8 single-arm trastuzumab deruxtecan (T-DXd) studies
    Meeting Abstract

    Powell, C. A.; Modi, S.; Iwata, H.; Takahashi, S.; Smit, E. F.; Siena, S.; Chang, D. Y.; Fuchs, C. S.; Nie, K.; Qin, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Updated results from DESTINY-breast01, a phase 2 trial of trastuzumab deruxtecan (T-DXd) in HER2 positive metastatic breast cancer
    Meeting Abstract

    Modi, S.; Saura, C.; Yamashita, T.; Park, Y. H.; Kim, S. B.; Tamura, K.; Andre, F.; Iwata, H.; Ito, Y.; Tsurutani, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • VICKI: A phase Ib/II, randomized, placebo-controlled, study of venetoclax plus ado-trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC)
    Meeting Abstract

    Lindeman, G. J.; Hamilton, E.; Krop, I.; Lim, B.; Modi, S.; Saura, C.; Desai, R.; Danner, B. J.; Fernando, T. M.; Kong, S.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • SGNLVA-001: A phase 1 open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer
    Meeting Abstract

    Beckwith, H. C.; Medgyesy, D. C.; Abraham, J.; Nanda, R.; Tkaczuk, K. H. R.; Krop, I. E.; Pusztai, L.; Modi, S.; Mita, M. M.; Specht, J. M.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Impact of online education regarding novel HER2 therapies on translating evidence to practice
    Meeting Abstract

    Parikh, K.; Dorkhom, N.; Chen, P.; Cameron, D. R.; Caraico, R.; Hanley, K.; Modi, S.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • The genomic landscape of breast cancer in African American women
    Meeting Abstract

    Serna-Tamayo, C.; Drago, J. Z.; Dos Anjos, C.; Herbert, J.; Pareja, F.; Modi, S.; Jhaveri, K.; Dang, C.; Solit, D. B.; Norton, L.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A phase 3, multicenter, randomized, open-label trial of [fam-] trastuzumab deruxtecan (T-DXd; DS-8201a) vs investigator's choice in HER2-low breast cancer (DESTINY-Breast04)
    Meeting Abstract

    Modi, S.; Ohtani, S.; Lee, C.; Wang, Y.; Saxena, K.; Cameron, D. A.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • [Fam-] trastuzumab deruxtecan (T-DXd; DS-8201a) in subjects with HER2-positive metastatic breast cancer previously treated with T-DM1: A phase 2, multicenter, open-label study (DESTINY-Breast01)
    Meeting Abstract

    Krop, I. E.; Saura, C.; Yamashita, T.; Park, Y. H.; Kim, S. B.; Tamura, K.; AndreĢ, F.; Iwata, H.; Ito, Y.; Tsurutani, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save